Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;14(7):2443-2446.
doi: 10.21037/jtd-2022-04.

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed

James L Shen  1 , Eric C Ko  2
Affiliations
Editorial

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed

James L Shen et al. J Thorac Dis. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2022-04/coif). The authors have no conflicts of interest to declare.

Comment on

  • J Thorac Dis. 14:2579.

Similar articles

See all similar articles

References

    1. Lester-Coll NH, Skelly J, Vacek PM, et al. Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer. J Thorac Dis 2022;14:2579-90. 10.21037/jtd-21-1835 - DOI - PMC - PubMed
    1. Amini A, Yeh N, Gaspar LE, et al. Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol 2014;9:210. 10.1186/1748-717X-9-210 - DOI - PMC - PubMed
    1. Iyengar P, Wardak Z, Gerber DE, et al. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol 2018;4:e173501. 10.1001/jamaoncol.2017.3501 - DOI - PMC - PubMed
    1. Palma DA, Olson R, Harrow S, et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. J Clin Oncol 2020;38:2830-8. 10.1200/JCO.20.00818 - DOI - PMC - PubMed
    1. Gomez DR, Tang C, Zhang J, et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol 2019;37:1558-65. 10.1200/JCO.19.00201 - DOI - PMC - PubMed

Publication types